Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.49 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.47 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.47 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.46 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10356118 | 1.00 | LTA4H (0.49) | LTA4HHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL27477537 | 1.00 | LTA4H (0.49) | LTA4HHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL21099020 | 0.94 | TBXAS1 (0.53) | LTA4HHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL372488 | 0.88 | CYP1A2 (0.48) | LTA4HMAPK1ALDH1A1CYP1A2CYP2D6 | |
| SCHEMBL12682235 | 0.88 | CYP1A2 (0.48) | LTA4HMAPK1ALDH1A1CYP1A2CYP2D6 | |
| SCHEMBL288399 | 0.88 | CYP1A2 (0.48) | LTA4HMAPK1ALDH1A1CYP1A2CYP2D6 | |
| Hydrochloric Acid SCHEMBL3017606 | 0.86 | CYP1A2 (0.47) | LTA4HMAPK1ALDH1A1CYP1A2CYP2D6 | |
| SCHEMBL21010165 | 0.84 | CYP2C9 (0.49) | TBXAS1ENPEPALDH1A1CYP1A2CYP2D6 | |
| SCHEMBL279848 | 0.84 | KMT2A (0.44) | ENPEPALDH1A1TSHR | |
| SCHEMBL1702547 | 0.82 | IDO1 (0.48) | SMN1; SMN2ENPEPALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107033043-B | N- replaces benzenesulfonyl-substituted benzene formyl amine compound and its prepares the purposes of drug | 中国人民解放军第二军医大学 | 2019-04-30 | — | — | CN | claimed |
| CN-107033043-A | N- replaces benzenesulfonyl-substituted benzene formyl amine compound and its prepares the purposes of medicine | 中国人民解放军第二军医大学 | 2017-08-11 | — | — | CN | claimed |
| WO-2020243402-A1 | SYNERGISTS FOR QUINACRIDONE MAGENTA PIGMENTS | CABOT CORPORATION (US) | 2020-12-03 | — | — | WO | disclosed |
| CN-106749373-B | Rubber additive and preparation and application thereof | 同济大学 | 2020-06-26 | — | — | CN | disclosed |
| US-20190359653-A1 | SELECTIVE PEPTIDE INHIBITORS OF FRIZZLED | GENENTECH INC (US) | 2019-11-28 | — | — | US | disclosed |
| CN-110494167-A | Composition and system for renal function measurement | MEDIBEACON INC | 2019-11-22 | — | — | CN | disclosed |
| CN-110461332-A | METHOD FOR PREPARING AND ANALYZING FLUORESCENT COMPOUNDS IN PLASMA | MEDIBEACON INC | 2019-11-15 | — | — | CN | disclosed |
| EP-3509616-A1 | SELECTIVE PEPTIDE INHIBITORS OF FRIZZLED | H. Hoffnabb-La Roche Ag (CH) | 2019-07-17 | — | — | EP | disclosed |
| WO-2018049275-A1 | SELECTIVE PEPTIDE INHIBITORS OF FRIZZLED | GENENTECH, INC. (US) | 2018-03-15 | — | — | WO | disclosed |
| WO-2017205786-A1 | CELL PERMEABLE PEPTIDOMIMETIC MACROCYCLES | AILERON THERAPEUTICS, INC. (US) | 2017-11-30 | — | — | WO | disclosed |
| EP-2895857-A2 | REGULATING BACILLUS ANTHRACIS LETHAL FACTOR ACTIVITY VIA AN ACTIVATING EPITOPE REGION | The United States of America, as represented by The Secretary, Health and Human Services (US) | 2015-07-22 | — | — | EP | disclosed |
| WO-2012024100-A2 | PROCESS FOR PREPARING AMINOCYCLOHEXYL ETHER COMPOUNDS | MERCK SHARP & DOHME CORP. (US) | 2012-02-23 | — | — | WO | disclosed |
| US-6645939-B1 | Very late antigen-4 (VLA) integrin antagonists; antiallergens, antiasthmatics, and antiinflammatory agents; multiple sclerosis, autoimmune disease treatment | MERCK & CO., INC. | 2003-11-11 | — | — | US | disclosed |
| EP-1196436-A2 | PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE | Bristol-Myers Squibb Pharma Company (US) | 2002-04-17 | — | — | EP | disclosed |
| US-6326372-B1 | BENIGN PROSTATE HYPERPLASIA | MERCK & CO., INC. | 2001-12-04 | — | — | US | disclosed |
| WO-2001002424-A2 | PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE | DU PONT PHARMACEUTICALS COMPANY (US) | 2001-01-11 | — | — | WO | disclosed |
| CN-1092767-A | Promote spiroperidol and homologue that tethelin discharges | MERCK & CO INC (US) | 1994-09-28 | — | — | CN | disclosed |
| US-5262436-A | Administering; enzyme inhibitor | SCHERING CORPORATION (US) | 1993-11-16 | — | — | US | disclosed |
| US-5061710-A | Atrial natriuretic factors | SCHERING CORPORATION (US) | 1991-10-29 | — | — | US | disclosed |
| US-4929641-A | DIURETICS, ANGIOTENSIN CONVERTING ENZYMES | SCHERING CORPORATION (US) | 1990-05-29 | — | — | US | disclosed |